Stock ZNTL ZENTALIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Zentalis Pharmaceuticals, Inc.

Equities

ZNTL

US98943L1070

Delayed Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
11.27 USD -0.09% Intraday chart for Zentalis Pharmaceuticals, Inc. -6.63% -25.61%
May. 24 Zentalis Says Azenosertib Combo Shows 'Promise' in Relapsed Osteosarcoma Trial MT
May. 23 Zentalis Pharmaceuticals, Inc. to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ZNTL Stock
  4. Revisions Zentalis Pharmaceuticals, Inc.